Enrollment for Phase III trials can be slower than average in neurology indications

This table compares the enrollment period and enrollment efficiency of Phase III trials conducted in the United States since 2015

Enrollment efficiency corresponds to the percentage achievement of the targeted enrollment population, where a value of 100% indicates that enrollment targets have been met.
Source: GlobalData, Pharmaceutical Intelligence Center, Clinical Trials database, Enrollment Module Get the dataCreated with Datawrapper